First Manhattan’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,200
Closed -$18.3K 975
2024
Q1
$18.3K Hold
1,200
﹤0.01% 1042
2023
Q4
$19.2K Hold
1,200
﹤0.01% 1031
2023
Q3
$15.6K Buy
1,200
+200
+20% +$2.6K ﹤0.01% 1065
2023
Q2
$12.7K Buy
+1,000
New +$12.5K ﹤0.01% 1099
2015
Q4
Sell
-2,940
Closed -$21K 1450
2015
Q3
$21K Sell
2,940
-120
-4% -$1.63K ﹤0.01% 1076
2015
Q2
$55K Sell
3,060
-1,470
-32% -$25.2K ﹤0.01% 945
2015
Q1
$71K Sell
4,530
-264,050
-98% -$4M ﹤0.01% 902
2014
Q4
$3.8M Sell
268,580
-167,300
-38% -$2.51M 0.02% 288
2014
Q3
$7.45M Sell
435,880
-13,007
-3% -$299K 0.04% 202
2014
Q2
$13.4M Sell
448,887
-829,314
-65% -$19.9M 0.08% 151
2014
Q1
$31.9M Buy
1,278,201
+488,888
+62% +$14.3M 0.21% 90
2013
Q4
$22.7M Buy
789,313
+556,377
+239% +$16.3M 0.15% 116
2013
Q3
$7.67M Buy
232,936
+208,116
+839% +$6.47M 0.05% 182
2013
Q2
$730K Buy
+24,820
New +$666K 0.01% 444

Other funds holding INVA

First Manhattan's INVA Position: Q2 2024 in Review

First Manhattan sold out of Innoviva (INVA) in Q2 2024, closing a stake of 1,200 shares — an estimated $18.3K sold.

First Manhattan first reported a position in INVA in Q2 2013 and held it in 14 quarters. The position peaked at $31.9M in Q1 2014. 213 funds tracked by Wall St. Rank hold INVA as of Q2 2024.

  • First Manhattan reported no remaining Innoviva position as of Q2 2024 after selling out during the quarter.
  • First Manhattan sold 1,200 Innoviva shares in Q2 2024, an estimated $18.3K.
  • First Manhattan first reported a position in Innoviva in Q2 2013 and held it in 14 quarters.
  • First Manhattan's Innoviva position peaked at $31.9M in Q1 2014.
  • 213 funds tracked by Wall St. Rank held Innoviva as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.